- Home
- PAPL vs ATNF Comparison
PAPL vs ATNF Comparison
Compare PAPL & ATNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAPL
- ATNF
- Stock Information
- Founded
- PAPL 2015
- ATNF 2016
- Country
- PAPL Canada
- ATNF United States
- Employees
- PAPL N/A
- ATNF N/A
- Industry
- PAPL Finance: Consumer Services
- ATNF Biotechnology: Pharmaceutical Preparations
- Sector
- PAPL Finance
- ATNF Health Care
- Exchange
- PAPL Nasdaq
- ATNF Nasdaq
- Market Cap
- PAPL 4.4M
- ATNF 4.6M
- IPO Year
- PAPL 2023
- ATNF N/A
- Fundamental
- Price
- PAPL N/A
- ATNF $1.40
- Analyst Decision
- PAPL Strong Buy
- ATNF
- Analyst Count
- PAPL 2
- ATNF 0
- Target Price
- PAPL $5.25
- ATNF N/A
- AVG Volume (30 Days)
- PAPL 455.1K
- ATNF 214.4K
- Earning Date
- PAPL 01-21-2025
- ATNF 02-13-2025
- Dividend Yield
- PAPL N/A
- ATNF N/A
- EPS Growth
- PAPL N/A
- ATNF N/A
- EPS
- PAPL N/A
- ATNF N/A
- Revenue
- PAPL $2,885,706.00
- ATNF N/A
- Revenue This Year
- PAPL $22.61
- ATNF N/A
- Revenue Next Year
- PAPL $30.00
- ATNF $54.15
- P/E Ratio
- PAPL N/A
- ATNF N/A
- Revenue Growth
- PAPL 32.40
- ATNF N/A
- 52 Week Low
- PAPL $0.41
- ATNF $1.16
- 52 Week High
- PAPL $2.14
- ATNF $17.75
- Technical
- Relative Strength Index (RSI)
- PAPL 45.69
- ATNF 39.49
- Support Level
- PAPL $0.47
- ATNF $1.31
- Resistance Level
- PAPL $0.52
- ATNF $1.51
- Average True Range (ATR)
- PAPL 0.05
- ATNF 0.11
- MACD
- PAPL -0.00
- ATNF 0.01
- Stochastic Oscillator
- PAPL 17.86
- ATNF 24.35
About PAPL Pineapple Financial Inc.
Pineapple Financial Inc is a Canada-based mortgage technology and brokerage company that provides mortgage brokerage services and technology solutions to Canadian mortgage agents, brokers, sub-brokers, brokerages, and consumers. Through its data-driven systems together with cloud-based tools, it offers advantages in the Canadian mortgage industry relative to alternative mortgage broker arrangements and also provides back office services.
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.